BVT.13
BVT.13 is a potent and selective oral PPARγ agonist with antidiabetic efficacy. It demonstrates full agonist activity comparable to rosiglitazone in vitro and reduces hyperglycemia in ob/ob mouse models, supporting its use in diabetes and metabolic syndrome research.
Product Specifications
CAS Number
756813-87-3
Product Name Alternative
BVT 13, BVT.13, BVT13, BVT-13
Field of Research
Metabolism Research, Molecular Biology
Purity
98.59% (May vary between batches)
Solubility
DMSO:3.2 mg/mL (7.92 mM)
Smiles
O=C (O) C1=CC (OC2=NC=CC=N2) =CC=C1NC (=O) C3=CC=C (Cl) C=C3Cl
Molecular Formula
C18H11Cl2N3O4
Molecular Weight
404.2
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
036906-FITC 200 µL
IGF1R, NT (K66) (IGF1R, Insulin-like growth factor 1 receptor, Insulin-like growth factor I receptor, CD221, Insulin-like growth factor 1 receptor alpha chain, Insulin-like growth factor 1 receptor beta chain) (FITC) discontinued
Sign In for Pricing
View Details 
NB100-93572AF594 0.1 mL
Rabbit Polyclonal SERPINB12 Antibody [Alexa Fluor 594]
Sign In for Pricing
View Details abx225114-01 50 µL
Cleft Lip And Palate Associated Transmembrane Protein 1 (CLPTM1) Antibody
Sign In for Pricing
View Details